Pharmaceutical Technology Europe-01-07-2011

Pharmaceutical Technology Europe

Using Excipients In Powder Formulations

January 07, 2011

Special Feature

23

1

During the past few years, we've seen a growing interest in direct oral application products, evidenced by the large amount of products already available on the market.

The Growth Of ODTs

January 07, 2011

Special Feature

23

1

Orally disintegrating tablets (ODTs) are growing in popularity and their market value could exceed $13 billion in sales by 2015, based on current global growth trends.

Will DTC Advertising Appear In Europe?

January 07, 2011

Industry Insider

23

1

Direct-to-consumer (DTC) advertising is firmly entrenched in the US, but has historically been considered as an inappropriate means of communication in Europe for prescription-only medicines.

Using Excipients With Biologics

January 07, 2011

Special Feature

23

1

Biologics are large molecular weight molecules primarily formulated for parenteral administration; however, there are some smaller biomolecules that have been formulated for oral use.

The Use Of UHPLC In Post-Drug Development

January 07, 2011

Ask the Expert

23

1

UHPLC offers increased performance compared with HPLC, including shorter analysis times and increased sensitivity.

Is There A Need For Stringent Regulations For Excipients?

January 07, 2011

Special Feature

23

1

Excipients should be regulated to manage risk. Although, excipients are an integral part of a finished pharmaceutical product, the issue of regulation is complex.

Printable Medicines: A Microdosing Device For Producing Personalized Medicines

January 07, 2011

Manufacturing

23

1

The authors describe a new method for the production of personalised medicines utilising ultra-precise microdrop printing technology.